EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synthesis and antimicrobial activity of sulfonyl-imidazole linked fused isoxazolo[3,4-b][1,2,3]triazolo[4,5-d]pyridines:PEG-400 mediated one-pot reaction under ultrasonic irradiation

Karukuri Premalatha, Ravikumar Kapavarapu, Sridhar Kavela, Sirassu Narsimha

Frontiers in Chemistry · 13.03.2026 · 14

DOI: 10.3389/fchem.2026.1784084 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Chemistry, online erschienen am 13.03.2026. Verfasst von Karukuri Premalatha und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Chaitanya (Deemed to be University), Hyderabad, India. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The rapid emergence of methicillin-resistant and vancomycin-resistant Staphylococcus aureus (MRSA and VRSA) represents a major global health challenge, necessitating the development of new antibacterial scaffolds with improved efficacy and safety.

Methods

In this study, a novel series of sulfonyl-imidazole-linked fused isoxazolo[3,4-b][1,2,3]triazolo[4,5-d]pyridine derivatives (6a–6o) was synthesized using a PEG-400-mediated, ultrasound-assisted one-pot Cu(I)-catalysed strategy under environmentally benign conditions. The synthesized compounds were evaluated for antibacterial activity against MSSA, MRSA, and VRSA strains, along with antibiofilm activity, hemolytic potential using mouse erythrocytes, and cytotoxicity in RAW 264.7, THP-1, and BoMac cells. Immunomodulatory effects were assessed through cytokine induction studies.

Results

Several derivatives exhibited potent antibacterial activity, with compound 6k emerging as the most active candidate, displaying MIC values of 1.56–3.12 μg/mL and outperforming the reference drug dicloxacillin. Selected compounds also showed significant antibiofilm activity against resistant S. aureus strains. Hemolysis and cytotoxicity assays demonstrated minimal toxicity, indicating good biocompatibility. Immunomodulatory analysis revealed moderate cytokine induction, suggesting a controlled immune response.

Discussion

Overall, compound 6k was identified as a promising lead with potent antibacterial, antibiofilm, and immunomodulatory properties, combined with a favourable safety profile, warranting further preclinical development against drug-resistant S. aureus infections.

Schlagwörter

Stichwörter der Autor:innen

MRSATLR4 dockingVRSAantibacterial agentsantibiofilm activityisoxazolo-triazolopyridinesultrasonication

Autor:innen und Institutionen

  • Department of Chemistry, Chaitanya (Deemed to be University), Hyderabad, India.
  • Department of Pharmaceutical Chemistry and Phytochemistry, Nirmala College of Pharmacy, Mangalgiri, Andhra Pradesh, India.
  • Department of Biotechnology, Chaitanya (Deemed to be University), Hyderabad, India.

Zitieren

APA

Premalatha, K., Kapavarapu, R., Kavela, S., & Narsimha, S. (2026). Synthesis and antimicrobial activity of sulfonyl-imidazole linked fused isoxazolo[3,4-b][1,2,3]triazolo[4,5-d]pyridines:PEG-400 mediated one-pot reaction under ultrasonic irradiation. Frontiers in Chemistry, 14. https://doi.org/10.3389/fchem.2026.1784084

Vancouver

Premalatha K, Kapavarapu R, Kavela S, Narsimha S. Synthesis and antimicrobial activity of sulfonyl-imidazole linked fused isoxazolo[3,4-b][1,2,3]triazolo[4,5-d]pyridines:PEG-400 mediated one-pot reaction under ultrasonic irradiation. Frontiers in Chemistry. 2026;14. doi:10.3389/fchem.2026.1784084

BibTeX
@article{Premalatha2026,
  author = {Premalatha, Karukuri and Kapavarapu, Ravikumar and Kavela, Sridhar and Narsimha, Sirassu},
  title = {Synthesis and antimicrobial activity of sulfonyl-imidazole linked fused isoxazolo[3,4-b][1,2,3]triazolo[4,5-d]pyridines:PEG-400 mediated one-pot reaction under ultrasonic irradiation},
  journal = {Frontiers in Chemistry},
  year = {2026},
  volume = {14},
  doi = {10.3389/fchem.2026.1784084}
}
Kostenlos starten →